Genetic basis of tumour development

Italian Journal of Gastroenterology

Volumn 28, Issue 4, 1996, Pages 232-245

  Ponz De Leon, M ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Cancer; Genes; Oncogenes; Tumour suppressor genes

Indexed keywords

ADENOMATOUS POLYP; BREAST TUMOR; CANCER GENETICS; CARCINOGENESIS; COLON POLYPOSIS; DIGESTIVE SYSTEM CANCER; DNA REPAIR; FAMILIAL CANCER; GENE MUTATION; HEREDITY; HUMAN; MEDICAL ETHICS; MEDICAL GENETICS; MUTATOR GENE; ONCOGENE; PATHOGENESIS; REVIEW; SOCIAL ASPECT; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADENOMATOUS POLYPOSIS COLI; BREAST NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMANS; LI-FRAUMENI SYNDROME; NEOPLASMS; ONCOGENES;

EID: 0029901646     PISSN: 03920623     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Matsukura N, Onda M, Tokunaga A, Yoshiyuki T, Shimizu Y, Nishi K, et al. Simultaneous gastric cancer in monozygotic twins. Cancer 1988; 62: 2430-5.
2. Cline MJ. The molecular basis of leukemia. N Engl J Med 1994; 330: 328-36.
3. Ponz de Leon M. Familial and hereditary tumors. Heidelberg: Springer-Verlag Publ, 1994; 1-347.
4. Haggitt RC, Reid BJ. Hereditary gastointestinal polyposis syndromes. Am J Surg Pathol 1986; 10(12): 871-87.
5. D'Andrea E, Menin C, Chieco-Bianchi L. Tumor suppressor genes: normal cell proliferation in leash. Trends Exper Clin Med 1992; 2: 311-29.
6. Knudson AG. All in the (cancer) family. Nature Genet 1993; 5: 103-4.
7. Knudson AG. Hereditary cancers disclose a class of cancer genes. Cancer 1989; 63: 1888-91.
8. Cowell JK, Hogg A. Genetics and cytogenetics of retinoblastoma. Cancer Genet Cytogenet 1992; 64: 1-11.
9. Coppes MJ, Haber DA, Grundy PE. Genetic events in the development of Wilms' tumor. N Engl J Med 1994; 331: 586-90.
10. Seizinger BR. NFl: a prevalent cause of tumorigenesis in human cancers. Nature Genet 1993; 3: 97-9.
11. Evans HJ. Molecular genetic aspects of human cancers: the 1993 Frank Rose Lecture. Br J Cancer 1993; 68: 1051-60.
12. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 1993; 329: 1318-27.
13. Malkin D. p53 and the Li-Fraumeni syndrome. Cancer Genet Cytogenet 1993; 66: 83-92.
14. Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D. High frequency of germline p53 muta-tions in childhood adrenocortical cancer. J Natl Cancer Inst 1994; 86: 1707-10.
15. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res 1992; 52: 3674-8.
16. Chang F, Syrjänen S, Syrjänen K. Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 1995; 13: 1009-22.
17. Cawkwell L, Quirke P. A new class of colorectal cancer gene. Gut 1995; 36: 641-3.
18. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, et al. Clues to the pathogene-sis of familial colorectal cancer. Science 1993; 260: 812-6.
19. Lindblom A, Tannergärd P, Werelius B, Nordenskjöld M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet 1993; 5: 279-82.
20. Peltomäki PT. Genetic basis of hereditary nonpolyposis colorectal carcinoma (HNPCC). Ann Med 1994; 26: 215-9.
21. Palombo F, Gallinari P, Iaccarino I, Lettieri T, Hughes M, D'Arrigo S, et al. GTBP, a 160-Kilodalton essential for mismatch-binding activity in human cells. Science 1995; 268: 1912-4.
22. Papadopoulos N, Nicolaides NC, Liu B, Parsons R, Lengauer F, Palombo F, et al. Mutations of GTBP in genetically unstable cells. Science 1995; 268: 1915-7.
23. Aaltonen LA, Peltomäki P, Mecklin JP, Järvinen H, Jass JR, Green JS, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994; 54: 1645-8.
24. Liu B, Farrington SM, Petersen GM, Hamilton SR, Parsons R, Papadopoulos N, et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Med 1995; 1: 348-52.
25. Karp JE, Broder S. Molecular foundations of cancer: new targets for intervention. Nature Med 1995; 1: 309-20.
26. Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parsons RE, Jen J, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 1995; 9: 48-55.
27. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994; 54: 5059-63.
28. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-38.
29. Weisburger JH. Causes, relevant mechanisms and prevention of large bowel cancer. Sem Oncol 1991; 18: 316-36.
30. Boland CR. The biology of colorectal cancer. Implications for pretreatment and follow-up management. Cancer 1993; 71: 4180-6.
31. Lynch HT, Fusaro RM, Lynch J. Hereditary cancer in adults. Cancer Detect Prev 1995; 19: 219-33.
32. Warthin AS. Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895-1913. Arch Intern Med 1913; 12: 546-55.
33. Lynch HT, Kimberling W, Albano WA, Linch JF, Biscone K, Schuelke JS, et al. Hereditary nonpolyposis colorectal cancer (Lynch syndrome I and II). Cancer 1985; 56: 934-8.
34. Lynch HT, Lanspa S, Smyrk T, Boman B, Watson P, Lynch J. Hereditary nonpolyposis colorectal cancer (Lynch syndrome I and II). Genetics, pathology, natural history and cancer control. Part I. Cancer Genet Cytogenet 1991; 53: 143-60.
35. Mecklin JP, Svendsen LB, Peltomäki P, Vasen HFA. Hereditary nonpolyposis colorectal cancer. Scand J Gastroenterol 1994; 29: 673-7.
36. Mecklin JP, Järvinen JA, Aukee S, Elomaa I, Karjalainen K. Screening for colorectal carcinoma in cancer family syndrome kindreds. Scand J Gastroenterol 1987; 22: 449-53.
37. Mecklin JP. Frequency of hereditary colorectal carcinoma. Gastroenterology 1987; 93: 1021-5.
38. Ponz de Leon M, Sassatelli R, Benatti P, Roncucci L. Identification of hereditary nonpolyposis colorectal cancer in the general population. Cancer 1993; 71: 3493-501.
39. Benatti P, Sassatelli R, Roncucci L, Pedroni M, Fante R, Di Gregorio C, et al. Tumor spectrum in hereditary nonpolyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population based study in Northern Italy. Int J Cancer 1993; 54: 371-7.
40. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145: 148-56.
41. Jacoby RF, Marshall DJ, Kailas S, Schlack S, Harms B, Love R. Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gastroenterology 1995; 109: 73-82.
42. Bülow S. Special section: premalignant conditions of the gastrointestinal tract. Familial adenomatous polyposis. Ann Med 1989; 21: 299-307.
43. Naylor EW, Lebenthal E. Gardner's syndrome. Recent developments in research and management. Dig Dis Sci 1980; 25: 945-59.
44. Bertoni G, Sassatelli R, Nigrisoli E, Tansini P, Roncucci L, Ponz de Leon M, et al. First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies. Gastroenterology 1995; 109: 374-80.
45. Bülow S. Familial polyposis coli. Danish Med Bull 1987; 34: 1-15.
46. Lynch HT, Smyrk TC, Lanspa SJ, Jenkins JX, Lynch PM, Cavalieri J, et al. Upper gastrointestinal manifestations in families with hereditary flat adenoma syndrome. Cancer 1993; 71: 2709-14.
47. Kropilak M, Jagelman DG, Fazio VW, Lavery IL, McGannon E. Brain tumors in familial adenomatous polyposis. Dis Colon Rectum 1989; 32: 778-82.
48. Foley TR, McGarrity TJ, Abt AB. Peutz-Jeghers syndrome: a clinicopathologic survey of the "Harrisburg family" with a 49-year follow-up. Gastroenterology 1988; 95: 1535-40.
49. Marra G, Armelao F, Vecchio FM, Percesepe A, Anti M. Cowden's disease with extensive gastrointestinal polyposis. J Clin Gastroenterol 1993; 16: 1-6.
50. Saul SH, Raffensperger E. Juvenile polyposis: intramucosal signet-cell adenocarcinoma arising in a polyp at a gastrojejunostomy site. Surg Pathol 1988; 1: 159-64.
51. Rustgi AK. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med 1994; 331: 1694-702.
52. Herrera L, Kakati S, Gibas L, Pietrzak E, Sandberg AA. Brief clinical report: Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986 25: 473-6.
53. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328: 614-9.
54. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-9.
55. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
56. Pozell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993; 329: 1982-7.
57. Caspari R, Friedl W, Mandl M, Möslem G, Kadmon M, Knapp M, et al. Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet 1994; 343: 629-32.
58. Leppert M, Burt R, Hughes JP, Samowitz W, Nakamura Y, Woodward S, et al. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med 1990; 322: 904-8.
59. Olschwang S, Laurent-Puig P, Groden J, White R, Thomas G. Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene. Am J Hum Genet 1993; 52: 273-9.
60. Henderson IC. Risk factors for breast cancer development. Cancer (Suppl) 1993; 71: 2127-40.
61. Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J. The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 1994; 179: 29-32.
62. Thompson WD. Genetic epidemiology of breast cancer. Cancer 1994; 74: 279-87.
63. Lynch HT, Lynch J, Conway T, Watson P, Feunteun J, Lenoir G, et al. Hereditary breast cancer and family cancer syndromes. World J Surg 1994; 18: 21-31.
64. Birch JM. Li-Fraumeni syndrome. Eur J Cancer 1994; 30A: 1935-41.
65. Lynch HT, Watson P, Conway TA, Lynch JF. Natural history and age at onset of hereditary breast cancer. Cancer 1992; 69: 1404-7.
66. Padberg GW, Schot JDL, Vielvoye GJ, Bots GTAM, de Beer FC. Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann Neurol 1991; 29: 517-23.
67. Eeles RA, Stratton MR, Goldgar DE, Easton DF. The genetics of familial breast cancer and their practical implications. Eur J Cancer 1994; 30A: 1383-90.
68. Meyn MS. High spontaneous intrachromosomal recombination rates in ataxia telangiectasia. Science 1993; 260: 1327-30.
69. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120-2.
70. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
71. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-90.
72. Hogervorst FBL, Cornelis RS, Bout M, van Vliet M, Oosterwijk JC, Olmer R, et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet 1995; 10: 208-12.
73. Boyd J. BRCA1: more than a hereditary breast cancer gene? Nature Genet 1995; 9: 335-6.
74. Lynch HT, Mulcahy GM, Harris RE, Guirgis HA, Lynch JF. Genetic and pathologic findings in á kindred with hereditary sarcoma breast cancer, brain tumors, leukemia, lung, laryngeal and adrenal cortical carcinoma. Cancer 1978; 41: 2055-64.
75. Birch JM. The Li-Fraumeni cancer family syndrome. J Pathol 1990; 161: 1-2.
76. Li FP. Cancer families: human models of susceptibility to neoplasia - the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1988; 48: 5381-6.
77. Li FP, Fraumeni Jr JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988; 48: 5358-62.
78. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni Jr JF, Li FP. Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 1991; 51: 6094-7.
79. Strong LC, Williams WR, Tainsky MA. The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics. Am J Epidemiol 1992; 135: 190-9.
80. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 1994; 57: 1-9.
81. Malkin D, Li FP, Strong LC, Fraumeni Jr JF, Nelson CE, Kim DH, et al. Germ-line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-8.
82. Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990; 348: 747-9.
83. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994; 54: 1298-304.
84. Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, et al. Prevalence and spectrum of germ-line mutations of the p53 gene among patients with sarcoma. N Engl J Med 1992; 326: 1301-8.
85. Hartley AL, Birch JM, Blair V, Kelsey AM, Harris M, Morris Jones PH. Patterns of cancer in the families of children with soft tissue sarcoma. Cancer 1993; 72: 923-30.
86. Eeles RA. Predictive testing for germline mutations in the p53 gene: are all the questions answered? Eur J Cancer 1993; 29A: 1361-5.
87. Maher ER. von Hippel-Lindau disease. Eur J Cancer 1994; 30A: 1987-90.
88. ++-transporting ATPase isoform 2 gene that resides in the Von Hippel-Lindau gene region. Cancer Res 1993; 53: 861-7.
89. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317-20.
90. Zeiger MA, Zbar B, Keiser H, Marston Linehan W, Gnarra JR. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma. Genes Chromosome Cancer 1995; 13: 151-6.
91. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994; 54: 2852-5.
92. Feldman GL, Kambouris M, Talpos GB, Mulligan LM, Ponder BA, Jackson CE. Clinical value of direct DNA analysis of the RET proto-oncogene in families with multiple endocrine neoplasia type 2A. Surgery 1994; 116: 1042-7.
93. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Müller-Brechlin R, Klein G, et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci 1988; 85: 1571-5.
94. Reiter RE, Anglard P, Liu S, Gnarra JR, Marston Linehan W. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 1993; 53: 3092-7.
95. Korf B. Molecular diagnosis. N Engl J Med 1995; 332: 1499-502.
96. Housman D. Human DNA polymorphism. N Engl J Med 1995; 332: 318-20.